Author response for "Effects of 6weeks treatment with dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: a randomized placebo-controlled exploratory study"

Published on Feb 8, 2021in Diabetes, Obesity and Metabolism5.9
· DOI :10.1111/DOM.14363/V2/RESPONSE1
Jonas Oldgren14
Estimated H-index: 14
,
Jonas Oldgren51
Estimated H-index: 51
+ 13 AuthorsPirjo Nuutila87
Estimated H-index: 87
Source
Abstract
📖 Papers frequently viewed together
2 Citations
105 Citations
95 Citations
References0
Newest
Cited By0
Newest